Ablation of Stage I–II Non–Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study
Florian J. Fintelmann, Alexander Graur, Karim Oueidat, Judit Simon, Jeanna M. Harvey Barnes, Shaunagh McDermott, Scott Genshaft, Terrance T. Healey, Robert D. Suh, Aaron Maxwell, Fereidoun Abtin
Abstract
Background: Treatment options for patients with interstitial lung disease (ILD) who develop stage I-II non-small cell lung cancer (NSCLC) are severely limited, since surgical resection, radiation, and systemic therapy are associated with significant morbidity and mortality.
Topics & Concepts
MedicineInterstitial lung diseaseStage (stratigraphy)LungLung cancerRetrospective cohort studyRadiation therapyMulticenter studyDiseaseRadiologySurgeryInternal medicineOncologyRandomized controlled trialBiologyPaleontologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedical Imaging and Pathology StudiesLung Cancer Diagnosis and Treatment